-
Abbisko Therapeutics and Lilly partner to develop new molecules
Pharmaceutical-Technology
January 19, 2022
Abbisko is eligible to receive up to $258m in milestone payments from Lilly.
-
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
prnasia
January 18, 2022
Collaboration Combines Abbisko Therapeutics' Proprietary Drug Discovery Platform with Lilly's Disease and Discovery Expertise.
Abbisko Therapeutics Is Eligible to Receive Research, Development and Commercial Milestone Payments.
-
'Dancing molecules' successfully repair severe spinal cord injuries
WorldPharmaNews
December 01, 2021
Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries...
-
Novel Raman spectroscopy method enables ultra-sensitive detection
europeanpharmaceuticalreview
May 26, 2021
The new surface-enhanced Raman spectroscopy (SERS) method uses capillary suction to actively capture target molecules for detection.
-
Enveric Biosciences acquires licence for Diverse Biotech’s novel molecules
pharmaceutical-technology
March 12, 2021
Enveric Biosciences has announced the acquisition of an exclusive and perpetual licence for Diverse Biotech’s novel molecules to treat oncology and other debilitating diseases.
-
New method to probe molecules could improve spectroscopy techniques
europeanpharmaceuticalreview
March 16, 2020
Researchers have developed a highly sensitive technique for probing molecules that they say could enable new applications in the fields of spectroscopy.
-
Insilico Medicine develops new AI drug discovery system
pharmaceutical-technology
September 04, 2019
Insilico Medicine has developed an artificial intelligence (AI)-powered system to facilitate the creation of therapeutic molecules.
-
Canadian researchers develop molecules to reverse memory loss
pharmaceutical-technology
February 18, 2019
Researchers at the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, have developed new therapeutic small molecules that could potentially reverse memory loss caused due to depression and ageing....
-
Molecules in spit may be able to diagnose and predict length of concussions: Research
biospectrumasia
November 24, 2017
Researchers measured the levels of microRNAs — tiny snippets of noncoding RNA — in the saliva of concussion patients
-
Bioversys AG and Aptuit announce collaboration to identify novel approaches to treat serious infecti
pharmaasia
March 21, 2017
Bioversys AG and Aptuit start on a joint collaboration aimed at the identification and validation of novel targets and molecules for Gram-negative bacteria.